Lumosa Therapeutics , Ltd. Intangible Assets

The latest intangible assets for 6535.TWO is $310K as of June 2026. That compares with $430K in the prior-year period — down 27.3% year over year. Investors often review this figure alongside Lumosa Therapeutics , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6535.TWO's intangible assets moved from $430K to $310K — a 27.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lumosa Therapeutics , Ltd.'s operating scale or balance-sheet position.

A intangible assets figure of $310K for 6535.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6535.TWO's intangible assets ($310K), review year-over-year change from $430K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lumosa Therapeutics , Ltd.'s intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.